ACRO BIOMEDICAL CO., LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $1.2M | $1.1K |
| FY2019 | — | $873.7K | $1.5K |
| FY2020 | — | $685.9K | $18.1K |
| FY2021 | — | $643.7K | $95.2K |
| FY2022 | — | $486.4K | $5.9K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $1.2M | $1.1K |
| FY2019 | — | $873.7K | $1.5K |
| FY2020 | — | $685.9K | $18.1K |
| FY2021 | — | $643.7K | $95.2K |
| FY2022 | — | $486.4K | $5.9K |